DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, R. J.
Right arrow Articles by Acosta, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, R. J.
Right arrow Articles by Acosta, D., Jr.

0090-9556/97/2506-0772-0777$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 6


SHORT COMMUNICATION
Metabolism of Ketoconazole and Deacetylated Ketoconazole by Rat Hepatic Microsomes and Flavin-Containing Monooxygenases

Rosita J. Rodriguez and Daniel Acosta, Jr.

Department of Pharmacology/Toxicology, College of Pharmacy, University of Texas at Austin (D.A.); and College of Pharmacy, Oregon State University (R.J.R.)

Ketoconazole (KT) has been reported to cause hepatotoxicity, which is probably not mediated through an immunoallergic mechanism. Although KT is extensively metabolized by hepatic microsomal enzymes, the nature, route of formation, and toxicity of suspected metabolites are largely unknown. Recent reports indicate that N-deacetyl ketoconazole (DAK) is a major initial metabolite in mice, which, like lipophilic 4-alkylpiperazines, is susceptible to successive oxidative attacks on the N-1 position producing ring-opened dialdehydes. The rate of formation of DAK from hepatic rat microsomal incubations of KT was determined by HPLC. The rate of disappearance for KT was almost equal to the rate of DAK formation: 5.96 and 5.88 µM/hr, respectively. Also, the potential bioactivation of DAK was evaluated by measuring substrate activity of DAK with purified pig liver flavin-containing monooxygenase (FMO) and rat liver microsomes. Activity was measured by following DAK-dependent oxygen uptake polarographically at 37°C in pyrophosphate buffer (pH 8.8) containing the glucose-6-phosphate NADPH-generating system. The KM's of DAK were 34.6 and 77.4 µM for the purified FMO and rat microsomal FMO, respectively. Lastly, DAK was found to be metabolized by an NADPH-dependent rat liver microsomal monooxygenases at pH 8.8 to two metabolites as determined by HPLC. Heat inactivation of rat liver microsomal FMO abolished the formation of these metabolites from DAK. SKF-525A and anti-rat NADPH cytochrome P450 reductase did not inhibit this reaction. These results suggest that deacetylation of KT yields a major product, DAK, for further metabolism by microsomal monooxygenases that seem to be FMO-related.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
H. M. Korashy, A. Shayeganpour, D. R. Brocks, and A. O.S. El-Kadi
Induction of Cytochrome P450 1A1 by Ketoconazole and Itraconazole but not Fluconazole in Murine and Human Hepatoma Cell Lines
Toxicol. Sci., May 1, 2007; 97(1): 32 - 43.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. T. Donato, N. Jimenez, J. V. Castell, and M. J. Gomez-Lechon
FLUORESCENCE-BASED ASSAYS FOR SCREENING NINE CYTOCHROME P450 (P450) ACTIVITIES IN INTACT CELLS EXPRESSING INDIVIDUAL HUMAN P450 ENZYMES
Drug Metab. Dispos., July 1, 2004; 32(7): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. R. Miller, G. A. Doss, and R. A. Stearns
IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT
Drug Metab. Dispos., February 1, 2004; 32(2): 178 - 185.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. J. Rodriguez and C. L. Miranda
Isoform Specificity of N-Deacetyl Ketoconazole by Human and Rabbit Flavin-Containing Monooxygenases
Drug Metab. Dispos., September 1, 2000; 28(9): 1083 - 1086.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. J. Rodriguez, P. J. Proteau, B. L. Marquez, C. L. Hetherington, C. J. Buckholz, and K. L. O'Connell
Flavin-Containing Monooxygenase-Mediated Metabolism of N-Deacetyl Ketoconazole by Rat Hepatic Microsomes
Drug Metab. Dispos., August 1, 1999; 27(8): 880 - 886.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.